Publication | Closed Access

Expression of the epidermal growth factor receptor and Her-2 are predictors of favorable outcome and reduced complete response rates, respectively, in patients with muscle-invading bladder cancers treated by concurrent radiation and cisplatin-based chemotherapy: A report from the Radiation Therapy Oncology Group

UrologyRadiation TherapyComplete Response RatesMedicineGenitourinary CancerMuscle-invading Bladder CancersConcurrent RadiationCancer TreatmentOncologyRadiation OncologyTumor Microenvironment